Accuray Incorporated (ARAY)
USD 1.45
(-2.03%)
USD 1.45
(-2.03%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 210.74 Million USD | 2.79% |
| 2023 | 205.03 Million USD | -4.07% |
| 2022 | 213.73 Million USD | 7.18% |
| 2021 | 199.4 Million USD | -10.06% |
| 2020 | 221.7 Million USD | 38.7% |
| 2019 | 159.84 Million USD | 21.95% |
| 2018 | 131.07 Million USD | -20.35% |
| 2017 | 164.57 Million USD | -21.79% |
| 2016 | 210.41 Million USD | 3.73% |
| 2015 | 202.85 Million USD | 3.7% |
| 2014 | 195.61 Million USD | -1.59% |
| 2013 | 198.76 Million USD | 150.13% |
| 2012 | 79.46 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 10.33 Million USD | 257.35% |
| 2005 | 2.89 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 210.74 Million USD | 2.79% |
| 2024 Q2 | 202.22 Million USD | -1.31% |
| 2024 Q4 | 210.74 Million USD | 1.82% |
| 2024 Q1 | 204.9 Million USD | -0.06% |
| 2024 Q3 | 206.99 Million USD | 2.36% |
| 2023 FY | 205.03 Million USD | -4.07% |
| 2023 Q1 | 205.31 Million USD | -3.94% |
| 2023 Q2 | 207.38 Million USD | 1.01% |
| 2023 Q3 | 205.02 Million USD | -1.14% |
| 2023 Q4 | 205.03 Million USD | 0.01% |
| 2022 Q4 | 213.73 Million USD | 6.06% |
| 2022 Q1 | 221.95 Million USD | 11.31% |
| 2022 Q2 | 204.11 Million USD | -8.04% |
| 2022 Q3 | 201.52 Million USD | -1.27% |
| 2022 FY | 213.73 Million USD | 7.18% |
| 2021 FY | 199.4 Million USD | -10.06% |
| 2021 Q1 | 210.65 Million USD | -4.98% |
| 2021 Q2 | 210.16 Million USD | -0.23% |
| 2021 Q3 | 210.37 Million USD | 0.1% |
| 2021 Q4 | 199.4 Million USD | -5.21% |
| 2020 Q4 | 221.7 Million USD | -1.16% |
| 2020 FY | 221.7 Million USD | 38.7% |
| 2020 Q1 | 221.1 Million USD | 38.32% |
| 2020 Q2 | 218.62 Million USD | -1.12% |
| 2020 Q3 | 224.31 Million USD | 2.6% |
| 2019 Q4 | 159.84 Million USD | 9.51% |
| 2019 Q1 | 128.92 Million USD | -1.64% |
| 2019 Q3 | 145.95 Million USD | 6.68% |
| 2019 Q2 | 136.82 Million USD | 6.13% |
| 2019 FY | 159.84 Million USD | 21.95% |
| 2018 Q2 | 169.87 Million USD | 7.5% |
| 2018 FY | 131.07 Million USD | -20.35% |
| 2018 Q4 | 131.07 Million USD | -2.42% |
| 2018 Q3 | 134.32 Million USD | -20.93% |
| 2018 Q1 | 158.02 Million USD | -3.98% |
| 2017 FY | 164.57 Million USD | -21.79% |
| 2017 Q4 | 164.57 Million USD | -3.21% |
| 2017 Q3 | 170.03 Million USD | -0.08% |
| 2017 Q1 | 175.02 Million USD | -16.82% |
| 2017 Q2 | 170.16 Million USD | -2.77% |
| 2016 Q1 | 204.77 Million USD | 0.95% |
| 2016 Q3 | 209.67 Million USD | 1.43% |
| 2016 Q4 | 210.41 Million USD | 0.35% |
| 2016 Q2 | 206.72 Million USD | 0.95% |
| 2016 FY | 210.41 Million USD | 3.73% |
| 2015 FY | 202.85 Million USD | 3.7% |
| 2015 Q4 | 202.85 Million USD | 0.93% |
| 2015 Q3 | 200.98 Million USD | 0.92% |
| 2015 Q2 | 199.15 Million USD | 0.9% |
| 2015 Q1 | 197.37 Million USD | 0.9% |
| 2014 Q1 | 199.91 Million USD | 0.58% |
| 2014 Q4 | 195.61 Million USD | -3.3% |
| 2014 Q2 | 201.08 Million USD | 0.58% |
| 2014 Q3 | 202.28 Million USD | 0.6% |
| 2014 FY | 195.61 Million USD | -1.59% |
| 2013 Q2 | 81.56 Million USD | 1.31% |
| 2013 Q3 | 197.65 Million USD | 142.33% |
| 2013 Q4 | 198.76 Million USD | 0.56% |
| 2013 FY | 198.76 Million USD | 150.13% |
| 2013 Q1 | 80.5 Million USD | 1.31% |
| 2012 Q3 | 78.46 Million USD | 1.28% |
| 2012 Q4 | 79.46 Million USD | 1.28% |
| 2012 FY | 79.46 Million USD | 0.0% |
| 2012 Q1 | 76.55 Million USD | 0.0% |
| 2012 Q2 | 77.46 Million USD | 1.19% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q1 | 19.49 Million USD | 88.58% |
| 2007 Q2 | - USD | -100.0% |
| 2006 FY | 10.33 Million USD | 257.35% |
| 2006 Q4 | 10.33 Million USD | 0.0% |
| 2005 FY | 2.89 Million USD | 0.0% |
| 2005 Q4 | 2.89 Million USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Envoy Medical, Inc. | 404 Thousand USD | -52065.099% |
| Delcath Systems, Inc. | 11.02 Million USD | -1811.191% |
| Xylo Technologies Ltd. | 10.75 Million USD | -1859.89% |